The investment seeks high current income consistent with what Franklin Advisers, Inc... Show more
Category IntermediateTermBond
A.I.dvisor tells us that PCRB and SPAB have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCRB and SPAB's prices will move in lockstep.
| Ticker / NAME | Correlation To PCRB | 1D Price Change % | ||
|---|---|---|---|---|
| PCRB | 100% | N/A | ||
| SPAB - PCRB | 7% Poorly correlated | -0.08% | ||
| BIV - PCRB | 1% Poorly correlated | -0.13% | ||
| AGG - PCRB | 1% Poorly correlated | -0.12% | ||
| SCHZ - PCRB | -0% Poorly correlated | -0.13% | ||
| DFCF - PCRB | -1% Poorly correlated | -0.09% | ||
More | ||||
The RSI Indicator for PCRB moved out of oversold territory on May 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 17 similar instances when the indicator left oversold territory. In of the 17 cases the stock moved higher. This puts the odds of a move higher at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for PCRB just turned positive on May 28, 2026. Looking at past instances where PCRB's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PCRB advanced for three days, in of 213 cases, the price rose further within the following month. The odds of a continued upward trend are .
PCRB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on June 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PCRB as a result. In of 57 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PCRB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for PCRB entered a downward trend on May 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.